Early Phase 1 Ovarian Cancer Trial, Recruiting NCT03068910 Sponsor: University of Virginia Condition: Ovarian Cancer
Back to Ovarian Cancer

Early Phase 1 Ovarian Cancer Trial, Recruiting

NCT03068910
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a girl who has gone through a mid-to-late stage of puberty (breast development at a certain level) and started your period no more than 2 years ago
  • You have higher-than-normal levels of male hormones (such as testosterone) in your blood, or you have clearly visible excess body hair (hirsutism)
  • You are in generally good health, apart from being overweight or obese, having high male hormone levels, or having a well-controlled thyroid condition
  • You (and your parent or guardian, if you are under 16) are willing and able to give your agreement to take part in the study
  • You are willing to avoid getting pregnant by using reliable non-hormonal birth control during the study

Who may not be able to join:

  • You are unable or not allowed to give your agreement to take part
  • You are male
  • Your obesity is caused by a known hormonal disorder or genetic condition
  • You are currently pregnant or breastfeeding
  • Your high male hormone levels or irregular periods appear to be caused by something other than a natural hormonal imbalance or PCOS (a common hormonal condition)
  • You show signs of strong male-like physical changes, such as rapidly increasing body hair, a deepening voice, or enlargement of certain body parts
  • Your total testosterone level is above 150 ng/dl, which could suggest a hormone-producing tumour (confirm with trial site)
  • A specific hormone called DHEA-S is more than 1.5 times the upper limit of the normal range (mild increases may still be accepted — confirm with trial site)
  • A hormone called 17-hydroxyprogesterone, measured early in the morning at a certain point in your cycle, is above 200 ng/dl, which could suggest a particular adrenal gland condition (further testing may be needed — confirm with trial site)
  • Your thyroid hormone level (TSH) is outside the normal range (note: a well-controlled thyroid condition with normal TSH is acceptable)
  • Your prolactin hormone level is more than 20% above the upper limit of normal (small increases may still be accepted — confirm with trial site)
  • You have signs or a history of certain hormonal conditions affecting the adrenal gland or pituitary gland, such as Cushing's syndrome, adrenal insufficiency, or acromegaly
  • You have signs of a condition where the body does not produce enough sex hormones (including a condition caused by extreme stress, very restrictive eating, or excessive exercise)
  • Your blood count (red blood cells) is persistently low, suggesting possible anaemia
  • Your platelet count or white blood cell count is severely low
  • You have been diagnosed with diabetes, or your fasting blood sugar or a related blood test result is above a certain level
  • You have ongoing abnormal liver test results (small increases may be accepted in some cases — confirm with trial site)
  • You have a significant history of heart or lung problems, such as heart failure or asthma that requires regular steroid treatment
  • Your kidneys are not working well enough (below a certain filtering level)
  • You have a personal history of breast, ovarian, or womb cancer
  • You have a history of any other cancer (except certain common skin cancers) unless you have been free of the disease for at least 5 years
  • You have had an allergic reaction to micronized progesterone or spironolactone (medications used in this study)
  • Your weight is too low for your age and height (BMI below the 5th percentile for your age)
  • You weigh less than 25 kg (about 55 lbs), due to the amount of blood needed for the study
  • You have taken certain medications in the past 2–3 months that can affect hormones, blood sugar, cholesterol, or blood pressure — these include the contraceptive pill, some diabetes medications, steroids, certain antipsychotics, and some stimulant medications (such as those used for ADHD)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Christine Burt Solorzano, M.D., University of Virginia Center for Research in Reproduction

Phone: 434-243-6911

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
21 July 2016
Est. completion
1 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Luteinizing hormone (LH) pulse frequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov